Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review
about
Financial conflicts of interest and reporting bias regarding the association between sugar-sweetened beverages and weight gain: a systematic review of systematic reviewsIndustry sponsorship and research outcomeAssociation between personal conflicts of interest and recommendations on medical interventionsComparative cardiovascular effects of thiazolidinediones: systematic review and meta-analysis of observational studiesConflict of interest disclosure in biomedical research: a review of current practices, biases, and the role of public registries in improving transparencyInadequate use and regulation of interventions against publication bias decreases their effectiveness: a systematic reviewConflict of interest reporting by authors involved in promotion of off-label drug use: an analysis of journal disclosuresConflicts of interest among authors of clinical practice guidelines for glycemic control in type 2 diabetes mellitusExpanding disease definitions in guidelines and expert panel ties to industry: a cross-sectional study of common conditions in the United StatesComprehensive evaluations of the adverse effects of drugs: importance of appropriate study selection and data sources.Knowledge of ghostwriting and financial conflicts-of-interest reduces the perceived credibility of biomedical research.Descriptions and interpretations of the ACCORD-Lipid trial in the news and biomedical literature: a cross-sectional analysisIs drinking to thirst optimum?Reporting of conflicts of interest from drug trials in Cochrane reviews: cross sectional study.A systematic appraisal of allegiance effect in randomized controlled trials of psychotherapyConflicts of interest and spin in reviews of psychological therapies: a systematic reviewPolitics and its intersection with coverage with evidence development: a qualitative analysis from expert interviews.Underreporting of conflicts of interest in clinical practice guidelines: cross sectional study.Contributors to primary care guidelines: What are their professions and how many of them have conflicts of interest?Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional studyDeclaration and Handling of Conflicts of Interest in Guidelines: A Study of S1 Guidelines From German Specialist Societies From 2010-2013Criminals in the Citadel and Deceit all along the Watchtower: Irresponsibility, Fraud, and Complicity in the Search for Scientific Truth.Conflict of interest disclosures for clinical practice guidelines in the national guideline clearinghouse.Industry influence in evidence productionDoes the pharmaceutical industry influence guidelines?: two examples from Germany.Systematic analysis of hydroxyethyl starch (HES) reviews: proliferation of low-quality reviews overwhelms the results of well-performed meta-analyses.Intraplaque haemorrhages as the trigger of plaque vulnerability.Secondary use of randomized controlled trials to evaluate drug safety: a review of methodological considerations.Drug safety assessment in clinical trials: methodological challenges and opportunitiesUndue industry influences that distort healthcare research, strategy, expenditure and practice: a review.Impact of choice of quality appraisal tool for systematic reviews in overviews.Association Between Financial Conflicts of Interests and Supportive Opinions for Erectile Dysfunction Treatment.Guidelines for reporting meta-epidemiological methodology research.Conflict of Interest Policies and Industry Relationships of Guideline Development Group Members: A Cross-Sectional Study of Clinical Practice Guidelines for Depression.Should primary care guidelines be written by family physicians? YES.[Les lignes directrices en soins primaires devraient-elles être rédigées par des médecins de famille? OUI].Demandes concurrentielles et possibilités en soins primaires.Competing demands and opportunities in primary care.Financial ties of principal investigators and randomized controlled trial outcomes: cross sectional study.Industry involvement in continuing medical education: time to say no.
P2860
Q21090126-6039E27C-7A84-4125-8FE1-1822744611EDQ24202591-FB003CBD-1353-461F-8E95-208F28C6E937Q24202627-45E802BF-9596-4B0B-BAC6-730BB19BA468Q24632655-3115D087-A1AB-4135-802D-EAA9BA61C84EQ24658631-13946D96-9EF0-4756-9A72-01F1D79659BBQ26995526-6EB263A8-6D20-4C8B-A834-CB2B67138D5EQ28482115-F37E48DF-7384-4545-AD18-A338F22A3073Q28534390-7AF3BAB0-5E25-41AA-9A4A-7FAB18CAA9DCQ28682030-0C3BA439-0A01-498D-A94F-0859E0E87667Q30840099-9195ACF3-536E-417C-805B-84C440D6B80BQ33807895-FC94B817-5B4F-478D-AF2B-6EDD19483BE6Q34014812-BA46D706-C716-42C9-A1C7-696A46F72F58Q34166493-955E24F2-A22F-4A9F-88FA-37BE17A0C976Q34294990-23972025-BC20-46D2-9B05-6F6CC2A31263Q34494570-D71FE34C-44C9-4F2B-BA2D-0F4C840FC6F9Q34523783-853F4527-B4CE-4CA2-9431-69E20690C6B4Q34623074-6439619E-7352-4B75-BE73-9703BB3FA8E7Q34705062-1390906D-7B99-4833-B7B3-E003629F2D86Q34994802-EC1F7077-449F-48E3-A402-3228D73EFE0AQ35316296-AC92A081-16A2-45CC-9FCD-80135B876AFEQ35891271-7F04CD74-3C77-4A86-B381-636881CE6EAEQ35964333-BC212ACF-232B-480E-82A6-5BF11E9A3666Q36380971-31D32BBA-3F6D-44CE-AA96-0B2FD1B02040Q36920494-46D188D3-C7F4-4E07-A821-F286F1D23B21Q37199193-A10BFC3B-DEAB-4668-8BA5-5FEA2B4CDA5AQ37199531-6C91ED20-6CA7-4222-8478-75B4ECE8164FQ37852494-4BA4DDCC-692F-4043-A440-89952F668B87Q37924038-DCF4C806-5403-4679-8473-37021C3FCCECQ38035953-C270371A-7D8A-4576-AACD-152D2B3C6263Q38092146-CA92AEEE-4465-495E-B249-99516EEB9C0DQ38243156-AD84167F-FFF1-4654-BC34-6CF385AA3C04Q38896860-8B852595-67CC-45CE-89EA-E02F8AE2B4A2Q39431249-F84B88B4-5BE3-4436-AC9F-75A611A28F06Q40424748-06151DE9-AE9E-45AC-8BEB-8AE99F7B4DFDQ41092566-27CD766D-350F-42B4-B583-74A06BB91FD3Q41092580-F86D5D99-78E8-478F-8E13-252F4DDBFF63Q41147928-88D5EE65-4D9B-421B-ABEE-3E94C75345CBQ41148616-C3E5A946-5FE4-434F-9BEC-D198C866FD90Q41742515-6FD384C7-75A3-49E0-A30A-1B78E267E42EQ41843609-1D87B17E-8F01-4831-92B0-FBB334C69874
P2860
Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Association between industry a ...... ss sectional systematic review
@ast
Association between industry a ...... ss sectional systematic review
@en
Association between industry a ...... ss sectional systematic review
@nl
type
label
Association between industry a ...... ss sectional systematic review
@ast
Association between industry a ...... ss sectional systematic review
@en
Association between industry a ...... ss sectional systematic review
@nl
prefLabel
Association between industry a ...... ss sectional systematic review
@ast
Association between industry a ...... ss sectional systematic review
@en
Association between industry a ...... ss sectional systematic review
@nl
P2860
P921
P356
P1433
P1476
Association between industry a ...... ss sectional systematic review
@en
P2093
Amy T Wang
Christopher P McCoy
P2860
P356
10.1136/BMJ.C1344
P407
P5008
P577
2010-03-18T00:00:00Z